Terminology Service for NFDI4Health
ALVAC-CEA (VCP248)
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2743
A replication-defective recombinant canarypox virus (ALVAC) that contains the entire human carcinoembryonic antigen (CEA) gene. Vaccination with ALVAC-CEA (VCP248) may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against CEA-positive tumor cells, thereby decreasing tumor growth. (NCI04) [ ]
Term info
Label
ALVAC-CEA (VCP248)
Synonyms
- ALVAC-CEA (VCP248)
Legacy Concept Name
ALVAC-CEA_VCP248
NSC Code
659643
Preferred Name
ALVAC-CEA (VCP248)
Semantic Type
Pharmacologic Substance, Immunologic Factor
UMLS CUI
C1515850
code
C2743
Term relations
Subclass of:
- ALVAC-CEA Vaccine
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Receptor Activation
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation